Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

IBB iShares Biotechnology ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.44%expense ratio
$11.1Bfund assets
+23.2%return, YTD
—return, 1 year
−$73Mnet flow, 1 month
+$1.2Bnet flow, 1 year
23.7%realized volatility, 1y
-9.7%worst drawdown, 1y
Top ten holdings
1GILD GILEAD SCIENCES8.96%
2AMGN AMGEN8.48%
3VRTX VERTEX PHARMACEUTICALS7.78%
4REGN REGENERON PHARMACEUTICALS6.51%
5MRNA MODERNA5.84%
6ARGX ARGENX SE3.77%
7NTRA NATERA3.00%
8BIIB BIOGEN2.54%
9ONC BeiGene2.42%
10RVMD REVOLUTION MEDICINES2.35%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.